News & Events


Recent Firm Activities and Highlights

FDA Leverages Private Sector Technology-Based Tools In Its Embrace Of Real World Evidence
07.09.19
The agency has signaled its apparent change of heart with speeches, policy guidance, and now with two public-private partnerships: the recent expansion of its agreement with Flatiron Health, and a brand new collaboration with COTA Healthcare. The Flatiron collaboration initially focused on patients being treated with immunotherapy for advanced non-small cell lung cancer; the new work concerns “the use of RWE in regulatory decision-making, including characterization of data quality, validation of reliable real-world clinical endpoints, collaboration on new analytic methodologies, and exploration of innovative applications such as real-world control arms.” The COTA collaboration will focus on breast cancer patients and treatment options. Read More
Boston Millennia Parters
Dana Callow to speak at Opal’s Family Office & Private Wealth Management Forum in Newport 7.23.19
07.10.19
As Opal Financial Group’s flagship event, The Family Office & Private Wealth Management Forum has become Opal’s largest family office event in the world. Known for its rich history and magnificent mansions, Newport, RI attracts thousands of delegates each year. The voyage begins with an annual Regatta Cup race, giving delegates an opportunity to find their inner competitor, and race across the harbor. In the course of three days, family offices, private investors, and investment managers navigate their way through the choppy waters of the past recession, while continuing to explore the best ways to map out their portfolios. With over 1000 delegates there is always an opportunity to meet potential clients. Discussions will cover a wide variety of investment topics including direct investing, impact investing, non-correlated assets, and many more. Come join us this July-- the forecast calls for fun, networking, and favorable prospects for preserving your family’s wealth. Read More
COTA Signs Research Collaboration Agreement With The U.S. Food and Drug Administration
05.29.19
COTA, Inc., a leading precision medicine technology company that uses real-world evidence to bring clarity to cancer care, today announced it has signed a two-year Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) Information Exchange and Data Transformation (INFORMED) Program, the Agency's data science and technology incubator supporting regulatory science research. This RCA will establish a study protocol with an initial focus on breast cancer, and will provide the FDA with information on the evolving treatment landscape, including insight on treatment variation within defined subpopulations of patients with the disease. As the project advances, the research may expand to other cancer types and explore disease characteristics, treatment patterns, and patient outcomes for the broader application of precision medicine. Read More
COTA to attend ASCO May 31st – June 4th, 2019
05.31.19
Attending #ASCO19 5/31-6/4? Stop by Booth #2063 to learn how COTA organizes fragmented, often hidden data from the real world to provide a clear view of cancer or schedule a demo with us here: meetus@cotahealthcare.comFind more details about the attending here. Read More
Forefront Telecare, Behavioral Health Solution for Rural Americans, Completes $15 Million Growth Equity Funding Round
04.24.19
Boston, MA, April 2019 Boston Millennia Partners IV is pleased to announce its investment in Forefront Telecare, Inc. as part of a $15 million growth equity round. Forefront is a leading provider of behavioral services via Telehealth to vulnerable populations across the country. With a focus on high acuity psychiatric patients in rural markets, Forefront offers services to hospitals, skilled nursing facilities, and clinics that have limited access to behavioral health practitioners. The solution consists of an extensive provider network, a modern video conferencing platform, and scalable in-house billing. The company currently serves over 175 customers and will be relocating headquarters to New Jersey. Read More
Health Decisions Appoints Sheila Kiss as Head of European Clinical Operations
03.31.19
Health Decisions, Inc., the full-service clinical research organization (CRO) of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, has appointed Sheila Kiss as Head of European Clinical Operations. With more than 35 years’ experience in Clinical Operations and Project Management, Kiss will support Health Decisions’ dedicated Clinical Operations Team to execute research in Women’s Health and In Vitro Diagnostic clinical development. Read More
MEDAPTUS NAMES DR. SUSAN KATZ SLISKI AS CHIEF NURSING OFFICER
02.05.19
Susan Katz Sliski, DNP, RN, CCM, FAAOHN has been named the Chief Nursing Officer (CNO) for MedAptus, Inc. In her role, Dr. Katz Sliski will be working closely with the product management team to promote and improve all MedAptus products, with a special focus on ASSIGN for Nurses, the company’s flagship patient assignment software for nurses. In her most recent role prior to joining MedAptus, Dr. Katz Sliski was leading REDESIGN initiatives within healthcare organizations to improve patient and provider experiences, drive organizational effectiveness and decrease costs. Read More
MedAptus
MEDAPTUS RANKED #1 IN KLAS RANKINGS FOR MOBILE CHARGE CAPTURE IN 2019
01.31.19
“This is one more indication of our commitment towards providing the very best charge management solutions in healthcare,” said Eugene Schneider, MedAptus president and CEO. “Whether it’s for professionals, facilities or even infusion coding services, our charge capture, management and reconciliation processes are consistently finding new sources of revenue for our customers. That’s extremely important as hospitals and other entities continue to tighten belts in this very challenging healthcare environment.” Read More
COTA
HIMSS19: The Importance of Data and Managing Expectations
02.01.19
It’s that time of year again! As we get ready for all that HIMSS has to offer and learn about exciting opportunities in healthcare, it’s important to manage expectations around what is going to be accomplished at the conference. It’s no surprise that HIMSS continues to get bigger and bigger every year, but many of the same things are still being discussed - Artificial Intelligence (AI), Machine Learning, Natural Language Processing, data security and improving efficiencies, to name a few. Read More
To Improve Treatments, Researchers Want To Hunt For Clues In Medical Records
07.15.18
When you go to your doctor's office, sometimes it seems the caregivers spend more time gathering data about you than treating you as a patient. Electronic medical records are everywhere – annoying to doctors and intrusive to patients. But now researchers are looking to see if they can plow through the vast amount of data that's gathered in those records, along with insurance billing information, to tease out the bits that could be useful in refining treatments and identifying new uses for drugs. Read More
Forefront Telecare, Behavioral Health Solution for Rural Americans, Completes $15 Million Growth Equity Funding Round
04.24.19
Boston, MA, April 2019 Boston Millennia Partners IV is pleased to announce its investment in Forefront Telecare, Inc. as part of a $15 million growth equity round. Forefront is a leading provider of behavioral services via Telehealth to vulnerable populations across the country. With a focus on high acuity psychiatric patients in rural markets, Forefront offers services to hospitals, skilled nursing facilities, and clinics that have limited access to behavioral health practitioners. The solution consists of an extensive provider network, a modern video conferencing platform, and scalable in-house billing. The company currently serves over 175 customers and will be relocating headquarters to New Jersey. Read Full Release
Boston Millennia Parters
BMP Insights March, 2018
03.14.18
2017 Yields Liquidity to Our Investors and a New BMP IV Partnership Begins Read Full Release
Boston Millennia Parters
Odyssey Logistics & Technology Expands Chicago Area Footprint to Better Serve Customer Capacity Issues
11.28.17
Danbury, Conn. (Nov. 28, 2017) – Odyssey Logistics & Technology Corporation (Odyssey) today announced that its subsidiary Linden Bulk Transportation LLC has recently expanded its bulk transportation footprint in Joliet, Illinois. The new location positions Odyssey to offer its customers additional capacity and services in the greater Chicago and Midwest region. Read Full Release
Boston Millennia Parters
Avizia Acquires Carena
10.10.17
Avizia, powering system-wide telehealth, today announced it has acquired Carena, a Seattle-based leading virtual care provider. The acquisition of Carena reinforces Avizia’s position as the largest and most comprehensive telehealth solutions partner for health systems nationwide. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company
08.30.17
Odyssey Logistics & Technology Corporation (Odyssey), a leading global logistics provider, announced today that an affiliate of The Jordan Company has signed a definitive agreement to become the new majority shareholder in Odyssey. Read Full Release
PAREXEL International
Two PAREXEL Executives Named to 2017 PharmaVOICE 100
08.01.17
BOSTON, August 1, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Sy Pretorius, M.D., Senior Vice President and Chief Scientific Officer, and Evan Demestihas, M.D., RPh, Vice President, Worldwide Head of The Medical Affairs Company (TMAC), have been named to PharmaVOICE magazine’s list of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2017 issue of PharmaVOICE, recognizes both leaders for their valuable contributions to the industry and dedication to improving patients’ lives, while also mentoring the next generation of industry leaders. Read Full Release
PAREXEL International
PAREXEL International Enters Definitive Agreement to be Acquired by Pamplona Capital Management for $88.10 Per Share in Cash
06.20.17
BOSTON and NEW YORK, June 20, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Pamplona Capital Management, LLP (Pamplona) today announced that they have entered into a definitive agreement under which Pamplona will acquire all of the outstanding shares of PAREXEL for $88.10 per share in cash in a transaction valued at approximately $5.0 billion, including PAREXEL’s net debt. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Posts Eight Percent Growth; Continues fourteen year trend of consecutive growth
02.02.17
Danbury, Conn. (Feb. 2, 2017) — Odyssey Logistics & Technology Corporation (Odyssey) announced today that it has posted fourteen consecutive years of growth, with net revenue up eight percent in 2016. The company attributes this year’s results to sustaining its leadership position in complex key markets, implementing operational efficiencies and maximizing benefits from the acquisition of Linden Bulk Transportation. Read Full Release
COTA
BMP Invests in COTA
12.20.16
Boston Millennia Partners Invests in Cota, Inc. Boston, MA, December 2016, Boston Millennia Partners is pleased to announce its investment in Cota, Inc. as part of an $18 million growth equity round. Cota is a New York City based cancer outcomes and data tracking company that uses a patented digital classification system to assess patient results on specific treatment protocols. Cota’s customers include pharmaceutical companies, healthcare providers and insurance companies. The company has partnerships with several major pharmaceutical companies in the U.S. including Novartis and Celgene, and with data provider Foundation Medicine. The company has received strategic investments from Novartis, Celgene, Foundation Medicine and Horizon Healthcare. Read Full Release
Collegium Pharmaceutical
Jeffries Key Takeaway: Another Formulary Win Further Positions Xtampza for a Potential 1H17 Inflection
12.15.16
COLL announced another formulary “win” for Xtampza following successful contracting with ESRX, the largest US pharmacy benefits manager (PBM). Starting January 1, 2017, Xtampza will be added to ESRX’s formulary as a preferred brand with access to another 28M commercial lives. Based on steady progress with the launch and managed care wins, we continue to believe that Xtampza Rxs are positioned for an inflection in 1H17 and see the drug as a $400M+ peak product. Read Full Release
Boston Millennia Parters
Dana Callow to speak at Opal’s Family Office & Private Wealth Management Forum in Newport 7.23.19
07.10.19
As Opal Financial Group’s flagship event, The Family Office & Private Wealth Management Forum has become Opal’s largest family office event in the world. Known for its rich history and magnificent mansions, Newport, RI attracts thousands of delegates each year. The voyage begins with an annual Regatta Cup race, giving delegates an opportunity to find their inner competitor, and race across the harbor. In the course of three days, family offices, private investors, and investment managers navigate their way through the choppy waters of the past recession, while continuing to explore the best ways to map out their portfolios. With over 1000 delegates there is always an opportunity to meet potential clients. Discussions will cover a wide variety of investment topics including direct investing, impact investing, non-correlated assets, and many more. Come join us this July-- the forecast calls for fun, networking, and favorable prospects for preserving your family’s wealth. Read Full Release
COTA to attend ASCO May 31st – June 4th, 2019
05.31.19
Attending #ASCO19 5/31-6/4? Stop by Booth #2063 to learn how COTA organizes fragmented, often hidden data from the real world to provide a clear view of cancer or schedule a demo with us here: meetus@cotahealthcare.comFind more details about the attending here. Read Full Release
MedAptus to Attend AONE Annual Conference
04.10.19
AONE provides nurse leader education programs for executives, directors, managers and clinical leaders. Topics range from health care finance, CENP and CNML review courses, shared governance and emerging leader competencies. AONE's annual meeting has over 50 concurrent sessions as well as multiple nationally known keynote speakers. Continuing education credits is available for most AONE programs. Read Full Release
COTA
HIMSS19: The Importance of Data and Managing Expectations
02.01.19
It’s that time of year again! As we get ready for all that HIMSS has to offer and learn about exciting opportunities in healthcare, it’s important to manage expectations around what is going to be accomplished at the conference. It’s no surprise that HIMSS continues to get bigger and bigger every year, but many of the same things are still being discussed - Artificial Intelligence (AI), Machine Learning, Natural Language Processing, data security and improving efficiencies, to name a few. Read Full Release
COTA
HIMSS18: Interview with Stuart Goldberg, M.D. | Cota | Precision Payment
03.29.18
On this episode we talk with Stuart Goldberg, MD, Chief Scientific Officer at Cota. Dr. Goldberg tells us all about Cota’s physician-led journey to organize and classify real-world evidence about every type of cancer. This effort led to something they call the Cota Nodal Address (CNA), and it’s enabling health systems to get very specific about the types of patients they’re treating, the costs associated with them, and the outcomes being achieved. This apples-to-apples comparison allows Cota to identify variation and address it in ways that are beneficial to the provider, payer and patient. It enables a concept Dr. Goldberg calls “Precision Payment”, which in turn enables proper bundled payment design, and precision medicine. Read Full Release
Odyssey Logistics & Technology
Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company
08.30.17
Odyssey Logistics & Technology Corporation (Odyssey), a leading global logistics provider, announced today that an affiliate of The Jordan Company has signed a definitive agreement to become the new majority shareholder in Odyssey. Read Full Release
Boston Millennia Parters
Dana Callow to Attend Harvard Medical School’s Precision Medicine 2017: Breakaway Business Models
06.21.17
In this year’s conference on Wednesday, June 21 (agenda below), we address the question of how to implement and disseminate these business models head on. Fortunately there are already several enterprises, some of them led by patients themselves, which provide us early answers to these questions. These are featured in our first panel entitled Early Disruptors in Precision Medicine. Read Full Release
PAREXEL International
Attend the lunch and learn with PRXL on Key Aspects of the FDA’s Drug Development and Review Programs
05.12.17
MassBio Lunch and Learn: Navigating Accelerated Approvals in Today’s Oncology Drug Development Landscape: Ensuring a Properly Tailored Approached Based on FDA Expectations and Current Trends in Drug Development Read Full Release
Boston Millennia Parters
Dana Callow to Speak on The State of The VC Market Panel
11.17.16
ACG Boston's regular networking breakfast returns to Serafina in Boston's financial district. Open to all, the Networking Breakfast is ACG Boston's signature event, where M&A professionals come to network and hear industry experts share their outlook, opinions, successes and failures. Join New England's M&A community on November 17 to hear a panel discussion on the current state of the VC market -- how the industry has evolved and where it's headed in the future. Read Full Release
Boston Millennia Parters
Dana Callow to speak at Opal’s Family Office & Private Wealth Management Forum in Newport 7.23.19
07.10.19
As Opal Financial Group’s flagship event, The Family Office & Private Wealth Management Forum has become Opal’s largest family office event in the world. Known for its rich history and magnificent mansions, Newport, RI attracts thousands of delegates each year. The voyage begins with an annual Regatta Cup race, giving delegates an opportunity to find their inner competitor, and race across the harbor. In the course of three days, family offices, private investors, and investment managers navigate their way through the choppy waters of the past recession, while continuing to explore the best ways to map out their portfolios. With over 1000 delegates there is always an opportunity to meet potential clients. Discussions will cover a wide variety of investment topics including direct investing, impact investing, non-correlated assets, and many more. Come join us this July-- the forecast calls for fun, networking, and favorable prospects for preserving your family’s wealth. Read Full Release
Boston Millennia Parters
Dana Callow to be Panelist at Funding Models in Biotech MBBP Life Sciences Series – Panel 3
09.22.16
Today’s financing environment for emerging biotech companies presents a number of challenges. Venture capital funds are ever more cautious about taking risk, and some players have departed the field at the early stage. Government grants have also closed their spigots in recent years, as the volume of government funding has plummeted dramatically. However, new players have entered the fray in the last few years, including family offices, super angels, strategic partners and foreign investors, replacing the investment dollars previously offered by institutional investors. So where does an emerging biotech company forage for precious dollars? Come join us on September 22nd at the CIC in Cambridge to hear a panel of experts discuss these trends. At the event, you will discover, among other ideas: Where and how to find the new players; What areas of interest are these players financing; How to optimize your chances of success; What are deal structures looking like? Read Full Release
Boston Millennia Parters
David Carney to Attend CED Tech Venture Conference
09.13.16
From early startups to growth-stage companies to highly successful businesses, the CED Tech Venture Conference reflects North Carolina’s vibrant entrepreneurial community and showcases many of the most-promising emerging companies in the region. Attendees will have the opportunity to connect with a diverse group of over 100 investors, from venture capital to corporate to angels, including funds such as Sequoia Capital, Greycroft, Grotech Ventures, and Comcast Ventures. Engage with industry leaders, radical thinkers and trail-blazing entrepreneurs, and learn about the disruptive innovations that are transforming the ways in which we live, work and play. Read Full Release
Boston Millennia Parters
Dana Callow to be on Lifescience Panel at the Richi Immersion Summer 2016 Program
07.21.16
Richi Social Entrepreneurs is a Richi Foundation initiative whose mission is to foster and catalyze the development of international Social Entrepreneurship ecosystems, taking Boston's unique case as our role model. Richi Social Entrepreneurs Immersion Summer 2016 is a one-month eye-opening experience in Boston. Social Entrepreneurs have the opportunity to explore Boston's advanced Social Innovation ecosystems, while working on their social value proposition and problem-solution fit. Social Entrepreneurs wear different hats, from startup founders in BioTech, HealthCare or Education, to professionals working in IT, CleanTech or Finance. It's not the industry that determines a project's potential social impact, it's the drive and motivation of the entrepreneur behind the idea. Read Full Release
Boston Millennia Parters
Dana Callow to Speak at Cancer Moonshot Summit
06.29.16
Boston Millennia Partners’ Dana Callow to Speak at Cancer Moonshot Summit. Simultaneous events will take place at the same time throughout the country to improve awareness of the program and gain support for funding research. Representatives from major pharmaceutical companies and service providers including Takeda, Syapse, and Foundation Medicine well as researchers from the area will speak about the Moonshot and their roles in finding a cure. The White House is sponsoring The National Cancer Moonshot summit. Vice President Joe Biden will speak on behalf of the program and subsequently there will be panel discussions by leading cancer specialists and patient advocates. As a Board Member of the National Leukemia Society Dana will address how non-profit organizations can positively impact the effort to find cures and improve patient care. Location: MGH Cancer Center, Lawrence House, 1st Floor Conference Room, 10 North Grove St., Boston MA Please contact liz@bmpvc.com for the speaker guide Read Full Release
PAREXEL International
PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016
06.20.16
BOSTON, June 20, 2016— PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52nd Annual Drug Information Association (DIA) meeting, held from June 26-30, 2016 in Philadelphia. Read Full Release
PAREXEL International
PAREXEL Announces Master Services Agreement with Pfizer
06.10.16
BOSTON, June 10, 2016 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc. Under the terms of this agreement, PAREXEL will continue to provide global clinical research and development services to Pfizer in support of clinical development programs across its portfolio. Terms of the agreement were not disclosed. Read Full Release
PAREXEL International
PRXL to Present at Cambridge Healthtech Institute’s Twelfth Annual Biomarkers & Diagnostics World Congresss 2016
05.18.16
Presentation: Wednesday, May 18 - 9:20 am Extending Precision Medicine Beyond Oncology Arlene Hughes, Senior Director, Genomic Medicine, Clinical Research Services Visit PAREXEL at Booth 4 in the Exhibit Hall. Read Full Release